- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Proprietary processing algorithms present challenges
Every mammogram is different, and every patient is her own control. Mammographers are watching for changes over time. But the digital age has brought with it some challenges. Because each digital mammography vendor uses proprietary processing algorithms, it may be hard to distinguish pathology from actual differences in image quality that can occur when images are scaled up. Everything scales differently.
Every mammogram is different, and every patient is her own control. Mammographers are watching for changes over time. But the digital age has brought with it some challenges. Because each digital mammography vendor uses proprietary processing algorithms, it may be hard to distinguish pathology from actual differences in image quality that can occur when images are scaled up. Everything scales differently.
For example, a nodule on a second-year mammogram might appear bigger than on the initial scan when it's scaled up. But each scan was taken on a different machine with different processing algorithms. Is the nodule actually bigger, or is it just scaled bigger?
I've looked at images from the same patient three years in a row, from three different units. And my question is, Does that mass or tissue look different because of processing algorithms, or has there been a real change?
Processing algorithms are the most variable aspects of digital mammography we face today. They improve image quality, no doubt, but they are vendor-specific and change every year when vendors introduce innovations.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.
